A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia | Zendy

Mariko Hojo | Zendy; Akihito Nagahara | Zendy; Daisuke Asaoka | Zendy; Tsutomu Takeda | Zendy; Kentaro Izumi | Zendy; Kohei Matsumoto | Zendy; Hiroya Ueyama | Zendy; Yuji Shimada | Zendy; Kenshi Matsumoto | Zendy; Shuko Nojiri | Zendy; Sumio Watanabe | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia

Author(s) -

Mariko Hojo,

Akihito Nagahara,

Daisuke Asaoka,

Tsutomu Takeda,

Kentaro Izumi,

Kohei Matsumoto,

Hiroya Ueyama,

Yuji Shimada,

Kenshi Matsumoto,

Shuko Nojiri,

Sumio Watanabe

Publication year - 2017

Publication title -

digestion

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.882

H-Index - 75

eISSN - 1421-9867

pISSN - 0012-2823

DOI - 10.1159/000477345

Subject(s) - famotidine , medicine , placebo , gastroenterology , pathology , alternative medicine

Acotiamide, a prokinetic drug, is used to treat functional dyspepsia (FD), especially postprandial distress syndrome (PDS). However, a treatment for FD patients with PDS and/or epigastric pain syndrome (EPS) has not been established. We investigated the efficacy of famotidine in combination with acotiamide for FD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research